Graves’ Disease during Immune Checkpoint Inhibitor Therapy (A Case Series and Literature Review)

Graves’ Disease during Immune Checkpoint Inhibitor Therapy (A Case Series and Literature Review)

Thyrotoxicosis is an adverse event associated with immune checkpoint inhibitors (ICPis) that occurs in 0.6 to 3.2% of treated patients, depending on ICPi class. Presentation usually consists of a biphasic thyroiditis with transient thyrotoxicosis and secondary hypothyroidism. ICPi-induced Graves’ di...

Full description

Bibliographic Details
Main Authors: Mathilde Peiffert, Christine Cugnet-Anceau, Stephane Dalle, Karim Chikh, Souad Assaad, Emmanuel Disse, Gérald Raverot, Françoise Borson-Chazot, Juliette Abeillon-du Payrat
Format: Article
Language:English
Published: MDPI AG 2021-04-01
Series:Cancers
Subjects:
Graves’ disease
immune checkpoint inhibitors
immune-related adverse event
endocrine toxicities
thyroid dysfunction
Online Access:https://www.mdpi.com/2072-6694/13/8/1944

Internet

https://www.mdpi.com/2072-6694/13/8/1944

Similar Items